NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed LSNE

Published date: 27 April 2021

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.

Closing: 26 May 2021, 1pm

Contract summary

Industry

Pharmaceutical products - 33600000

Location of contract

WA7 2ES

Value of contract

£1,520

Procurement reference

CF-0186600D0O000000rwimUAA1

Published date

27 April 2021

Closing date

26 May 2021

Closing time

1pm

Contract start date

24 June 2021

Contract end date

31 January 2023

Contract type

Supply contract

Procedure type

Open procedure (below threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Description

NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed LSNE:
Offer reference number: CM/PHG/21/5639/00
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months)
FIND A TENDER (FTS) Reference number: 2021/S 000-008845
Potential periods of call-offs under the framework agreement:
24/06/2021 to 31/01/2023 (19 months) LSNE region.

More information

Links

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kTv7/H091RbtdxywdJK0sAgWLUYhLvfo_746uWaj3FJCRoKU
Document No. 05a (ii) CM_PHG_21_5639_00 SELECTT Application

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kTug/WTw12JadLsCoAJ0WiUm0Nxw1ptAtfL5iyRFKK.Kk_ho
Document No. 08 - Confidential information schedule

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kTuT/hInBQVgbkX6BQEf.tAdCvyED7j2RdEtxRQHz2WKPuHY
Document No. 01 - Invitation to offer covering letter

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kTuy/Dsby.B8h8nGpy.TFF0qJ9uMDg1i.26lN8rQ.YHMvK74
Document No. 06 - Form of offer

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kTui/4tYoXZjT7iKrWS8dmJvb26ZxpWjX8hY4RWeSqHBWfx4
Document No. 05a (i) Product Listing and Usage - Transition (CM_PHG_21_5639_00)

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kTuf/HZMw9zYhkNdsJHfUdhKu2.JvpFT_jUHo6TR9dkymJa4
Document No. 09 - Stability Data Requirements

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kTv3/HMjoCRPOXXxl8xQClaZR4OQ4dk.YZNWKEeuRiehHys0
Qualification Questionnaire - Transition 2021_2 - Pemetrexed Solution for Infusion LSNE

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kTv2/s9yKeFXyN14.4mvIQUnJnKLLYW7RxbwhFTCYvJdq0Uo
Document No. 07b - Guidance for performing a risk assessment of licensed medicines for the NHS

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kTud/UHrNif4WQG5d_Yr_EBR35kAtWMjjlwdqkHg9_.bWWqI
Document No. 03 - Framework Agreement and Terms and Conditions

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kTuY/lvlML3i5Q96CuHSGnue.moq_h9.qQhPVX5OvGIh6f7Y
Document No. 02 - Terms of Offer

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kTue/NsLhRDkdVneODSWC4aTgwr8A7Ueg7q.YAoswlySLwsM
Document No. 07a - Quality control technical sheet

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kTux/aU3mAyOp6FHyx0ghOjZttWvzBYm0SUX4jpEIW2LrvEc
Document No. 05b - Selectt offer schedule instructions

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kTus/kx9tENi8Yrvn7r0iIwXwnvGvjzmW3icdBizEX40cK.Q
Document No. 04 - Contract technical specification

About the buyer

Contact name

Lynne Tierney

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
GB

Email

lynne.tierney@nhs.net